Search This Blog

Wednesday, November 6, 2019

Coherus BioSciences EPS beats by $0.10, beats on revenue

Coherus BioSciences (NASDAQ:CHRS): Q3 GAAP EPS of $0.63 beats by $0.10.
Revenue of $111.68M beats by $4.98M.
Shares +3.28%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)